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Introduction:  The objective of this study was to examine the maximal indices of cardiopulmonary exercise response in patients with aortic 
stenosis (AS), which have never been studied before on a large cohort.
Methods: We included 367 consecutive patients with varying degree of AS who were referred for cardiopulmonary testing (CPX) at Cardiovascular 
Health Clinic, Mayo Clinic between January 1991 and April 2009. These patients underwent standard symptom limited CPX, and continuous 
monitoring of heart rate, blood pressure, and electrocardiogram was performed. We compared their CPX variables with a contemporaneous cohort of 
individuals without known structural heart disease who presented with exertional dyspnea or fatigue (No AS, n=1480).
Results: Mean age was 52.25 + 15.76 and 65.96 + 14.14 in no-AS (69% males) and AS (83% males) group respectively. About 48% of AS patients 
were on beta blockers as compared to 19% in no-AS groups. Mean body mass index was 28.90 + 5.22 and 28.72 + 5.87 in AS and no-AS groups. 
Peak oxygen uptake (VO2 max), predicted VO2, Oxygen pulse, expired ventilation (VE), and carbon dioxide output (VCO2) were significantly reduced 
in AS patients as compared to no-AS individuals, even after adjustment (Table1).
Conclusion: Severe abnormalities in maximal indices of pulmonary gas exchange were noticed in a cohort of AS patients. The reasons for 
abnormalities could be reduced stroke volume, ventilation-perfusion mismatch, and/or abnormal peripheral oxygen utilization. 
Variable
AS group
(n=367)
No-AS group
(n=1480)
Unadjusted p value
Adjusted #
difference 
Multivariable* p value
VO2 max 1656.16 + 656.13 2195.47 + 833.49 <0.0001 203.07 <0.0001
VO2/kg 19.21 + 7.27 25.86 + 9.75 <0.0001 2.33 <0.0001
% predicted VO2 74.97 + 23.50 82.44 + 25.28 <0.0001 0.082 <0.0001
VCO2 1822.89 + 802.94 2479.08 + 997.46 <0.0001 274.60 <0.0001
VE 67.68 + 24.51 74.10 + 27.95 <0.0001 7.321 0.001
Oxygen pulse 12.57 + 4.16 13.97 + 4.63 <0.0001 .66 0.036
VO2/Body surface area 807.55 + 293.62 1077.98 + 380.46 <0.0001 97.27 <0.0001
#Difference between measured and adjusted value after general linear model multivariate analysis
*Multivariable p value was obtained after adjusting for age, gender, use of beta blocker and BMI.
